Lupus-related transverse myelitis is a rare but serious complication. A 25-year-old Japanese womanwith systemic lupus erythematosus (SLE) was admitted because of numbness of the face and left upper extremity, headache, and intermittent fever. Six days later, she developed tetraplegia. MRI of the spinal cord showed longitudinal high intensity signals from medulla oblongata to C5, and from Thl2 to conus medullaris on T2-weighted image. These MRI findings wereconsistent with acute catastrophic neurological abnormalities. Despite administration of the combination of methylprednisolone and cyclophosphamide pulse therapies, as well as plasmapheresis, her condition did not improve. Any vasculopathy in addition to the autoimmune pathogenesis, and narrow therapeutic windowmayrelate to the present refractory case. (Internal Medicine 41: 156-160, 2002) 
Introduction
Anysymptomof the central nervous system can be involved in systemic lupus erythematosus (SLE), such as headache, cognitive dysfunction, seizures, psychosis, cerebral infarction, and so on. Abnormal electroencephalogramscan occur in about 70% of patients with SLE, and cerebrospinal fluid (CSF) shows elevated protein levels and increased mononuclear cells in 30% of the patients (1) . Computed tomography (CT) and angiograms are most likely positive when focal neurologic deficits are present, however these modalities are less helpful in cases with diffuse manifestations.
Transverse myelitis is a rare but serious complication of SLE, and the laboratory diagnosis is difficult. A recent report on the first case of extensive SLE-related transverse myelitis demonstrated that magnetic resonance imaging (MRI) is the most sensitive method to assess the severity and extension of the SLErelated transverse myelitis (2) . Wereport a patient with SLE-related transverse myelitis with longitudinal involvement of the spinal cord from the medulla oblongata to C5, and from Thl2 to conus medullaris, and extending to the left thalamus and right pontine of the brain. The MRIfindings were consistent with acute catastrophic-onset of neurological abnormalities associated with extensive longitudinal transverse myelitis.
Case Report
A25-year-old Japanese womanwas admitted because of numbnessof the face and left upper extremity, headache, and intermittent fever from 2 weeks previously. Nine years earlier, she was hospitalized for autoimmunehepatitis with laboratory findings of elevated antinuclear antibody (ANA) >x640 (speckled, peripheral, homogeneous type), immune complex (anti-Clq antibody method) 67.7 |ig/ml (normal range <34.5), immune complex (anti-C3d antibody method) 12 Blood cell counts, liver and renal function were all within normal range. Laboratory examinations showed elevated CRP (3.8 mg/dl), ANA>x640 (speckled, peripheral, homogeneous type) and anti SS-A antibody 200.8 U/ml. Anti-DNA antibody (RIA) and anti-ds DNAantibody were within the normal range, however C3 50 mg/dl (50-95), C4 15 mg/dl (15-40), and CH50 Figure 1 . A-C; Lumbar MRI3 days after admission showed high intensity signals from Thl2 to conus medullaris on T2weighted image, which were not enhanced by gadolinium. These findings were compatible with all sensorial palsy of right lower limb, bladder and rectal dysfunction, and lower extremities paralysis.
20.0 mg/dl (20.0-45.0) were slightly low. Immune complex was <1.5 |ig/ml (anti-Clq antibody method, <3.0), 10.3 ng/ml (anti-C3d antibody method, <13). TAT (5.0 | ig//), PIC (2.0 jig/ ml), D-dimer (4.2 jig/ml), and FDP (15.6 jig/ml) were all elevated, and suggested secondary fibrinolysis accompanied with accelerated coagulation cascade. APTTwas normal, and cardiolipin IgG antibody, anti-cardiolipin-p2GPI antibody and lupus anticoaglant (PNP, APTTmethod) were also within normal range. Electroencephalogram showed burst of 2.5 Hz, which was a nonspecific finding in CNSlupus. CTscan of the brain showed atrophy in the anterior lobe. Three days after admission, she developed motor and sensory palsy of bilateral lower extremities, and acute urinary retention requiring balloon catheter drainage. A lumber puncture revealed elevated white cell counts 83/mm3, elevated protein concentration 168 mg/dl and lowered glucose level 33 mg/ dl. Interleukin-6 (IL-6) in CSF was elevated as high as 13,600 pg/ml. IgG index in CSF was also elevated to 1.9 (normal range <0.70), which indicated polyclonal B cell activation in CNS lupus (3) . A gram stain of CSF was negative. CSF cultures were also negative for microorganisms. Oligoclonal band in CSFwas also negative. MRIof the brain showed a high intensity spotty signal at the left substantia nigra. MRI of the lumbar spine revealed a longitudinal high intensity signal at the level from Thl2 to the conus medullaris ( Fig. 1A-C ). According to the laboratory data and MRfindings, it was thought her condition was related to SLE related CNSinvolvement. However, as viral, bacterial and fungal meningitis could not be eliminated from her diagnosis, antibiotic medications (cefpirom, acyclovir and amphotericin B) and methylprednisolone pulse therapy (1,000 mg /day for 3 days) were started from the third hospital day. However, she had worsening of headache, neck pain, and continuous fever in the range of 38-39°C. Four days after admission, the neurological findings were further deteriorated: central facial palsy, bilateral horizontal nystagmus for the right side, absolute sensory disturbance of the left upper extremity, all sensory paralysis of the L1-S3 area on both sides, and motor paralysis of bilateral lower extremities.
Bilateral patellar tendon reflex had absolutely disappeared and bilateral Babinski's reflex was positive. Five days later, she became tetraplegic, and showed left-sided medial longitudinal fasciculus syndrome. MRIdisplayed extension of the high intensity signal in the left thalamus, right pontine, left red nucleus and around these regions (Fig. 2) , and gray matter of the spinal cord extending from the medulla oblongata to C5 (Fig. 3A, B) , and from Thl2 to conus medullaris on T2-weighted images. Gadoliniumshowedno enhancementand the anterior spinal artery was not occluded. Mwave was not induced by nerve conduction velocity study on bilateral tibial nerve, indicating peripheral nerve disturbance in the bilateral lower extremities.
Onthe other hand, bilateral median nerve conduction velocity was relatively within normal limit. She refused further nerve conduction velocity studies. Anti-ganglioside antibody (GM 1 , GM2, GM3, GDla, GDlb, GD3, GTlb, GQlb, GA1, Gal-C) in CSF was negative.
After methylprednisolone pulse therapy for 3 days, intrave- Figure 2 . Brain MRI6 days after admission showed high intensity signals at left thalamus, left red nucleus and around these region. Gadolinium did not enhance them. These findings were compatible with central facial palsy and medial longitudinal fasciculus syndrome. nous prednisolone 60 mg/day was succeeded. Despite the corticosteroid pulse therapy, she did not have any remission in neurological findings. At the 14th hospital day, although serum immunecomplexwas not elevated, cyclophosphamidepulse therapy using 750 mg/month accompanied by prednisolone (60 mg/day), and synchronized plasmapheresis per week were additionally performed because of her worsening condition. At the end of third cyclophosphamide pulse therapy and ninth plasmapheresis (3 months after the admission), ANA(xl60) and anti SS-A antibody (<10 U/ml) were lowered. CH50 42.9 mg/ dl, C3 80 mg/dl, C4 34 mg/dl levels were restored. However, her neurological disturbances were hardly improved. At this time, the brain magnetic resonance angiography (MRA)discovered significant stenosis at the right internal carotid artery and diffuse stenotic changes in bilateral cerebral arteries (Fig.  4) . Depending on there finding, antiplatelet therapy (ticlopidine) was started.
Four months later, CSF findings including IgG index and IL-6 showedcomplete resolution of the abnormalities. Although the symptoms and neurological abnormalities were hardly improved, cyclophosphamide pulse therapy and plasmapheresis were terminated because of the complete resolution of CSF abnormalities and improvements in elevated autoantibodies. She continued prednisolone therapy in which the dosage gradu- Figure 3 . A, B; Cervical MRI3 months after admission showed high intensity signal from medulla oblongata to C6 on T2weighted image, which was the same finding as that assessed 6 days after admission. These abnormal findings were compatible with loss of superficial sensory and motor palsy of the bilateral upper extremities.
ally decreased for each 10% dose every 2 weeks, and antiplatelet medication (ticlopidine) for the suppression of thrombotic and stenotic changes of bilateral cerebral arteries. Even one year after hospitalization, the neurological disturbances were not improved, and she is bedridden, requiring urine catheterization and enema. 
Discussion
Neuropsychiatric manifestations are present in about 60% of patients of SLE, howevertransverse myelitis is an uncommonbut life threatening complication, and the prevalence has been estimated to be approximately 3% (4) . Acute transverse myelitis usually presents as an early stage complication of SLE. The meantime interval between the diagnosis of SLE and the occurrence of acute transverse myelitis is reported to be 38 months (5) . The time interval between the onset of neurological symptomsand maximumneurological deficits ranges from hours to months, but is usually less than 24 hours. Ropper et al found three types of the disease onset: a smoothly progressive onset with ascending neurological symptoms; a subacute gradually developing type; and a hyperacute, catastrophic-onset type. Of these, the hyperacute catastrophic-onset with the development of total neurological deficit within 12 hours especially followed by the development of tetraplegia and bladder and rectal dysfunction had the worst predicted prognosis (6).
Spinal cord involvement of this disorder occurs commonly at the cervical level and the mid to lower thoracic level, and most often extends four vertebrae in length (2, (4) (5) (6) (7) (8) . MRI is the most sensitive methodto assess the severity and extension of this disorder. MRIfindings in the present case showed spinal lesion from the level of medulla oblongata extended to C6, and Thl2 to conus medullaris, which were clearly visualized as a longitudinal high intensity signal on T2-weighted image, and was not enhanced by gadolinium. Similar findings are also observed in viral myelitis, intoxication or multiple sclerosis.
Based on her long history of SLE, and clinical symptoms, and the lack of findings of microorganism infection, no intoxica-Internal Medicine Vol. 41, No. 2 (February 2002) tion to penicillins and no oligoclonal band in CSF, these findings were considered to be compatible with previous reports of SLE-related transverse myelitis (4) (5) (6) (7) (8) (9) . Symptoms and physiological findings in the present case; urinary and rectal dysfunction, facial nerve palsy, medial longitudinal fascicular syndrome, numbness of the left limb and bilateral upper extremities, deficiency of all sensation of right limb, and tetraplegia were relatively compatible with the visualized longitudinal spinal lesions of this disorder on MRIassessments. Although the lumbar lesion on MRIdisappeared after intensive treatments, her rectum and bladder dysfunction and paralysis of bilateral lower extremities could not be improved. Irreversible peripheral neuropathy and persistent of damage in the upper motor neuron (damage of cervical spinal cord) may be associated with limitation of improvement. The present case did not respond to the intensive medical treatments which consisted of corticosteroid pulse therapy, cyclophosphamide pulse therapy, and synchronized plasmapheresis. Several reports have demonstrated clinical efficacy of the cyclophosphamide pulse therapy (9), steroid therapy, and synchronized plasmapheresis ( 10) . Due to the rarity of this disorder, no prospective randomized investigations are available to evaluate these therapies, and the efficacy of synchronized plasmapheresis also remains uncertain. Recent reports have described that early aggressive therapy using the combination of corticosteroid and cyclophosphamide or azathioprine is associated with satisfactory outcome (4, 1 1). In 14 patients with this disorder, Kovacset al comparedthe therapeutic effectiveness of the three therapeutic modalities or combinations: corticosteroid pulse therapy, cyclophosphamide pulse therapy and plasmapheresis ( 1 2). They reported that patients receiving corticosteroid pulse therapy alone or those receiving combination of corticosteroid pulse therapy and cyclophosphamide pulse therapy showed better recovery compared to those receiving all three combinations (60%, 40%, 0%). In their analysis, more aggressive treatment was not necessarilly associated with better outcome. Lack of response to the intensive treatments in the present case may be due to the relatively narrow therapeutic window in the case of acute onset (8) . Magneticresonance angiographic findings of diffuse stenotic lesions in cerebral arteries and laboratory data presenting secondary fibrinolysis accompanied with accelerated coagulation cascade suggested that any vasculopathy in addition to the autoimmunepathogenesis may have been related to the acute development of longitudinal transverse myelitis in the present refractory case.
